跳至主要内容
临床试验/NCT04454541
NCT04454541已完成不适用

The Efficacy of Ultrasound -Guided Multifidus Cervicis Plan Block Versus Greater Occipital Nerve Block for Cervicogenic Headache

Abha International Private Hospital1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2019年5月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
60
试验地点
1
主要终点
Headache free

研究概览

简要总结

Background: Cervicogenic headache (CH) described as a chronic hemi-cranial pain resulted from a disorder of the cervical spine and its anatomic structures innervated by the C1, C2, and C3 cervical spinal nerves. Traditionally noninvasive and invasive techniques were used for treatment. Greater occipital nerve block is the most frequent peripheral nerve block invasive technique used for the management of cervicogenic headache Objectives: The study was done to compare the efficacy of two different techniques: multifidus cervicus plan block and greater occipital nerve block in treatment of refractory cervicogenic headache using ultrasound guided.

Patients and Methods: sixty patients with cervicogenic headache were recruited and diagnosed according to ICHD-ш Beta version. Divided into two group, one for greater occipital nerve block and the other for multifidus cervicis plane block with ultrasound guided.

详细描述

This study was done to compare the efficacy of two different techniques: multifidus cervicus plane block and greater occipital nerve block in treatment of cervicogenic headache using ultrasound guided.

This prospective study that was approved by Institutional Review Board (IRB), Mansoura Faculty of Medicine, Mansoura University, Cairo Egypt (Code Number: R/19.04.483) and all participants gave written informed consent. The procedures followed were in accordance with our protocol.

This study included patients with cervicogenic headache disorders that diagnosed according to International Classification of Headache Disorder version III (ICHD-III beta version) criteria (18)

Full clinical neurological examination was done for all patients. Blood samples for routine laboratory investigations (Complete blood count, creatinine, liver function tests, PT, APTT) were taken from all patients, electrocardiography (ECG) were done for all patients. Pain intensity was evaluated via visual analog scale (VAS) scores (0 -10). Pain intensity evaluation will be done at initial presentation then after 2 and 4 weeks, using the VAS scale for affected side of cervicogenic headache. Saturation of pulse oxygen (SpO2), all Procedures performed using ultrasound system with a 7 - 13 MHz multi-frequency transducer (LOGIQ P5; GE Healthcare).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • History of occipital nerve injection, occipital nerve stimulation or history of surgical procedures in the occipital region,

排除标准

  • History of allergic reaction to the substance to be applied as local anesthetic.,
  • Pregnancy or lactation,
  • Uncontrolled hypertension,
  • Uncontrolled diabetes mellitus,
  • Uncompensated congestive heart failure,
  • Chronic renal failure,
  • Chronic liver disease,
  • Tumor and/or vascular disease,
  • Inflammatory and/or infectious diseases,
  • Anticoagulant or antiplatelet medication use that may interfere with the injection process were also excluded.

结局指标

主要结局

Headache free

时间窗: 30 minute post intervention

次要结局

  • Visual analog scale (VAS)(4 Weeks)

研究者

发起方
Abha International Private Hospital
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验